Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Panel advances bill to ban 'white‑bagging' and 'brown‑bagging' in specialty drug delivery
Summary
A Senate committee advanced House Bill 17 to prohibit insurer or PBM‑directed 'white bagging' and 'brown bagging' for infused specialty drugs, with supporters saying the practices delay treatment and raise quality concerns for patients and providers.
A Senate committee on an administrative agenda reported House Bill 17 after a presentation from Senator Boyd, who said the bill would prohibit so‑called 'white bagging' and 'brown bagging' practices by insurers and pharmacy benefit managers.
Senator Boyd said the measures can impede timely care. "White bagging... can delay the patient's treatment, anywhere from 10 to 14 days oftentimes," he said,…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
